Retention in care at 12 months will be measured. 12 month retention is defined as being alive at 12 months and having a care visit between 9 and 15 months after enrollment.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 41 | |
| FANMI - Cohort Care | 44 |
Last reviewed · How we verify
FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti
NA trial testing FANMI - Cohort Care in HIV in 120 participants. Completed in 1 October 2023.
| Lead sponsor | Weill Medical College of Cornell University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 120 |
| Start date | 25 May 2018 |
| Primary completion | 1 June 2022 |
| Estimated completion | 1 October 2023 |
| Sites | 1 location across Haiti |
Weill Medical College of Cornell University
Adults 16 to 23, female only, with HIV. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Retention in care at 12 months will be measured. 12 month retention is defined as being alive at 12 months and having a care visit between 9 and 15 months after enrollment.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 41 | |
| FANMI - Cohort Care | 44 |
Viral suppression at 12 months will be measured. Suppressed viral load will be defined as a binary outcome based upon the WHO definition of viral suppression as a plasma HIV-1 RNA level \<1000 copies/µl.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 26 | |
| FANMI - Cohort Care | 28 |
Time to ART initiation is the number of calendar days from date of HIV diagnosis to date of ART initiation.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 0 | 0 – 0 |
| FANMI - Cohort Care | 0 | 0 – 0 |
ART adherence will be measured by self-report using two questions: 1) number of pills missed in the past 4 days and 2) forgot to take pills last weekend. A response of no missed pills in the past 4 days and did not forget to take pills last weekend is defined as 'optimal' adherence. All other responses are defined as 'sub-optimal' adherence.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 22 | |
| FANMI - Cohort Care | 18 |
Sexual risk behavior will be measured by regular condom use among those who are sexually active. Regular condom use is defined as a response of 'often' or 'always' when asked about condom use during sexual intercourse.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 21 | |
| FANMI - Cohort Care | 26 |
Sexually Transmitted Infections will include syphilis, diagnosed using a serum RPR (HUMAN) followed by a treponemal test if positive (Bioline Standard Diagnostics), chlamydia and gonorrhea, diagnosed by the urine GeneXpert GT/NG assay.
| Group | Value | 95% CI |
|---|---|---|
| Standard-of-care | 10 | |
| FANMI - Cohort Care | 20 |
The investigators will conduct a randomized controlled trial of Group Care in the GHESKIO Community Center versus Individual Care in the GHESKIO Adolescent Clinic for 160 HIV-infected adolescent girls age 16-23 years in Haiti (80 adolescents per arm). Group Care includes receiving integrated clinical and social support services in groups of 5-8 adolescents at a monthly visit. The primary outcome is retention in HIV care at 12 months after randomization.
3 peer-reviewed publications reference this trial (live from Europe PMC):
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03286504.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing